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Abstract
Cancer cells and stromal cells cooperate by exchanging diffusible factors that sustain tumor
growth, a form of frequency-dependent selection that can be studied in the framework of
evolutionary game theory. In the case of multiple myeloma, three types of cells (malignant
plasma cells, osteoblasts and osteoclasts) exchange growth factors with different effects,
and tumor-stroma interactions have been analysed using a model of cooperation with pair-
wise interactions. Here we show that a model in which growth factors have autocrine and
paracrine effects on multiple cells, a more realistic assumption for tumor-stroma interac-
tions, leads to different results, with implications for disease progression and treatment. In
particular, the model reveals that reducing the number of malignant plasma cells below a
critical threshold can lead to their extinction and thus to restore a healthy balance between
osteoclast and osteoblast, a result in line with current therapies against multiple myeloma.
Introduction
The production of growth factors is one of the most important determinants of cancer devel-
opment [1]. Clones producing different growth factors can sustain each other’s growth [2, 3],
and non-producer cells can rely on the growth factors diffusing from neighboring cells [4].
The production of growth factors by cancer cells, therefore, is a form of cooperation that can
be studied in the framework of evolutionary game theory [5, 6].
Cancer cells also produce diffusible factors that induce stromal cells to release other
growth factors that support tumor proliferation [7]. Consider, for example, multiple mye-
loma, a type of cancer of plasma cells [8–10] in which different cell types—malignant plasma
cells (MM) themselves, as well as osteoclasts (OC) and osteoblasts (OB)—contribute to bone
resorption and bone formation by exchanging diffusible factors (Fig 1). In a healthy bone,
osteoclasts demolish bone tissue and osteoblasts regenerate it, two processes that balance
each other maintaining bone health. MM cells produce cytokines like interleukin-1 (IL-1),
IL-3, tumor necrosis factor (TNF-α), receptor activator of nuclear factor-kB ligand
(RANKL) and macrophage inflammatory protein (MIP-1α), which activate OC, and conse-
quently increase resorption. MM cells also produce factors, such as IL-1 and Dickkopf-
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related protein 1 (DKK-1), which have inhibitory effects on OB differentiation. Multiple
myeloma, therefore, alters the normal OB-OC equilibrium and induces, among other symp-
toms, bone fracture. Some factors like IL-3 have stimulatory effects on OC and inhibitory
effects on OB differentiation. OC also secretes growth factors like MIP-1 and IL-6 that affect
MM cell proliferation [11, 12]. In short, each cell type has stimulatory or inhibitory effects
on the other types and on itself, leading to frequency-dependent selection, which can be ana-
lyzed using evolutionary game theory.
Multiple myeloma has been analyzed before in the framework of evolutionary game the-
ory by Dingli et al. [13] using a model with pairwise interactions, that is, assuming that the
effect of the growth factors produced by each cell is limited to one other companion cell. The
growth factors produced by cancer and stromal cells, however, have autocrine and paracrine
effects on multiple cells, therefore it would be more appropriate to model the effect of growth
factors as a multiplayer game with collective interactions, rather than pairwise. While models
with pairwise interactions are often used in game theory, it is known that their results cannot
always be extended to games with collective interactions, and can actually lead to misleading
conclusions [14].
Fig 1. Bone remodeling in multiple myeloma. Multiple myeloma cells (MM) produce growth factors that activate
osteoclasts (OC), which increase bone resorption, or that inhibit osteoblast (OB) differentiation. OC and OB secrete
growth factors that affect each other and MM cells.
doi:10.1371/journal.pone.0168856.g001
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Model
Fitness functions
Assume that there are n phenotypes in a population denoted by P1. . .Pn. Each phenotype can
produce one of n diffusible factors G1. . .Gn, respectively. Each diffusible factor j has a different
effect (ri,j) on the other phenotypes i (for example, G1 can confer a net benefit on P1 and P2,
and cause a cost to P3). Therefore, if there are Nj individuals of type Pj among the other group
members (where N1+N1+. . .+Nn = N, and N is the number of cells within the diffusion range
of the growth factors), the payoff for strategy Pj is:
pPjðN1;N2; . . . ;NnÞ ¼
ðNj þ 1Þcj
N
rj;j þ
Xn
i¼1;i6¼j
Ni  ci
N
rj;i   cj ð1Þ
Where ci (for i 2{1,. . .,n}) is the contribution of (that is, the cost for) Pi for growth factor Gi,
and ri,j is the multiplication factor that specifies the effect of Gj on individuals belonging to
type Pi. For example, in a game with three phenotypes, the above equation would yield:
pP1ðk; j; lÞ ¼
ðkþ 1Þc1
N
r1;1 þ
jc2
N
r1;2 þ
lc3
N
r1;3   c1; ð2Þ
pP2ðk; j; lÞ ¼
kc1
N
r2;1 þ
ðjþ 1Þc2
N
r2;2 þ
lc3
N
r2;3   c2; ð3Þ
pP3ðk; j; lÞ ¼
kc1
N
r3;1 þ
jc2
N
r3;2 þ
ðl þ 1Þc3
N
r3;2   c3; ð4Þ
Where k, j, and l are the numbers of individuals that invest in the growth factors G1, G2 and G3
respectively.
Dynamics in infinite populations
In a well-mixed, infinite population we assume, as is standard, that groups are formed at ran-
dom at each generation, after which fitness is calculated. Let us call x, y and z the frequencies
of P1, P2 and P3 in the population, respectively (x+y+z = 1). N is the number of cells within the
diffusion range of the growth factors, S is the number of individuals belonging to either type
P1 or P2, and m is the number of individuals of type P1. Fitness is calculated by weighting the
payoffs obtained in the randomly formed groups, weighted by the probability that such groups
occur. The probability that a group contains S-m-1 individuals of type P2, N-S individuals of
type P3 and m individuals of type P1 (in addition to the focal individual) is given by B (S-1,
N-1, 1-z) × B (m, S-1, x/(1-z)), where:
Bðx; n; pÞ ¼
n
x
 !
pxð1   pÞn  x ð5Þ
Therefore, the payoff for P1 is:
f1ðS;mÞ ¼
ðmþ 1Þc1
N
r1;1 þ
ðS   m   1Þc2
N
r1;2 þ
ðN   SÞc3
N
r1;3
 
ð6Þ
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and the fitness function for P1 is:
W1 ¼
XN
S¼1
½BðS   1;N   1; 1   zÞ
XS  1
m¼0
B m; S   1;
x
1   z
 
 f1ðS;mÞ   c1 ð7Þ
Likewise, the fitness functions for P2 and P3 are given by:
W2 ¼
XN
S¼1
½BðS   1;N   1; 1   xÞ
XS  1
m¼0
B m; S   1;
y
1   x
 
 f2ðS;mÞ   c2 ð8Þ
W3 ¼
XN
S¼1
½BðS   1;N   1; 1   yÞ
XS  1
m¼0
B m; S   1;
z
1   y
 
 f3ðS;mÞ   c3 ð9Þ
where
f2ðS;mÞ ¼
ðmþ 1Þc2
N
r2;2 þ
ðS   m   1Þc3
N
r2;3 þ
ðN   SÞc1
N
r2;1
 
ð10Þ
f3ðS;mÞ ¼
ðmþ 1Þc3
N
r3;3 þ
ðS   m   1Þc1
N
r3;1 þ
ðN   SÞc2
N
r3;2
 
ð11Þ
The fitness functions can be reduced to:
W1 ¼ f1ðð1   zÞðN   1Þ; xðN   1ÞÞ   c1 ð12Þ
W2 ¼ f2ðð1   xÞðN   1Þ; yðN   1ÞÞ   c2 ð13Þ
W3 ¼ f3ðð1   yÞðN   1Þ; zðN   1ÞÞ   c3 ð14Þ
Let us denote with x(t), y(t) and z(t) the frequencies of phenotypes P1, P2 and P3, respec-
tively. We assume that the frequencies change according to the replicator dynamics [15]:
_xðtÞ ¼ xðtÞðW1   WÞ; ð15Þ
_yðtÞ ¼ yðtÞðW2   WÞ; ð16Þ
_zðtÞ ¼ zðtÞðW3   WÞ; ð17Þ
where W ¼ xW1 þ yW2 þ zW3. The equilibria of the system can be found by setting Equation
set Eqs 15–17 equal to zero [15].
Dynamics of diffusible factors production in multiple myeloma
We follow Dingli et al. [13] in their assumptions on the effect of each cell on another. Essen-
tially OC and OB cells are in equilibrium in the absence of MM cells, while MM and OC cells
have a stimulatory effect on each other, and MM cells inhibit OB cells and OB cells have little
or no effect on MM cells [8–12, 16, 17]. Table 1 summarizes these effects, while Table 2
describes the parameters used. We can assume that ri,i = 0 that is, each cell type has no net
effect on itself. This does not mean that there are no autocrine effects; it implies, instead, that
production and consumption of the growth factors are linear measures of the density of the
cell types (MM cells, for instance, produce IL6 that stimulate MM cell proliferation: the more
MM cells, the more IL6 is available, but also used by more MM cells). By setting ri,i = 0 we
Evolutionary Dynamics of Multiple Myeloma
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imply that the balance changes only due to paracrine effects (in this case, the number of OC
cells). rMM,OB = 0 because GOB (i.e., the diffusible factors produced by OB) has no effect on
MM. rOB,OC = rOC,OB because OB and OC balance each other; for the same reasons rMM,OC =
rOC,MM.
Given the values in Table 2 and Eqs 12–14, the fitness of the three types of cells are:
WOC ¼ ðbc3z þ ac2yÞðN   1Þ=N   c1 ð18Þ
WOB ¼ ðac1x   dc3zÞðN   1Þ=N   c2 ð19Þ
WMM ¼ bc1xðN   1Þ=N   c3 ð20Þ
Eqs 15–17 and 18–20 can be used to investigate the evolutionary dynamics of the three cell
types over time.
Results
Clearly, the three vertices of the simplex (xOC = 1, xOB = 0, xMM = 0), (xOC = 0, xOB = 1, xMM =
0) and (xOC = 0, xOB = 0, xMM = 1) are fixed points of the game. Other fixed points are the
three points on the edge of the simplex:
xOC ¼
ac2ðN   1Þ þ ðc2   c1ÞN
aðc1 þ c2ÞðN   1Þ
; xOB ¼
ac1ðN   1Þ þ ðc2   c1ÞN
aðc1 þ c2ÞðN   1Þ
; xMM ¼ 0
 
xOC ¼
bc3ðN   1Þ þ ðc3   c1ÞN
bðc1 þ c3ÞðN   1Þ
; xOB ¼ 0; xMM ¼
bc1ðN   1Þ þ ðc3   c1ÞN
bðc1 þ c3ÞðN   1Þ
 
xOC ¼ 0; xOB ¼
dc3 þ ðc3   c2   c3dÞN
c3dðN   1Þ
; xMM ¼
  2dc3 þ ð  c3 þ c2 þ 2c3dÞN
c3dðN   1Þ
 
ð21Þ
8
>
>
>
>
<
>
>
>
>
:
Table 1. Multiplication factors for diffusible factors produced by osteoclasts (OC), osteoblasts (OB) and multiple myeloma cells (MM).
Phenotypes Diffusible factors
GOC GOB GMM
OC neutral equilibrium stimulation
OB equilibrium neutral inhibition
MM stimulation neutral neutral
doi:10.1371/journal.pone.0168856.t001
Table 2. Multiplication factors for tumor-stroma interactions in multiple myeloma.
Diffusible factors
Effect on GOC GOB GMM
OC 0 a b
OB a 0 -d
MM b 0 0
doi:10.1371/journal.pone.0168856.t002
Evolutionary Dynamics of Multiple Myeloma
PLOS ONE | DOI:10.1371/journal.pone.0168856 December 28, 2016 5 / 17
and one in the interior of the simplex:
xOC ¼
bc2c3N þ c12Nða   bÞ   c32Nðbþ dÞ þ c1fbc2N þ c3½ab þ ðN   1Þðb2 þ bdÞ   aðbþ 1ÞN þ dNg
½a2c1c2   abc1ðc2 þ c3Þ þ ac2c3d þ bc1c3ðbþ dÞðN   1Þ
;
xOB ¼
abc1c2 þ a2c1c2ðN   1Þ þ bc1ðc1   c2ÞN   a½c12 þ bc1c2 þ c22   ðc1 þ c2Þc3N
½a2c1c2   abc1ðc2 þ c3Þ þ ac2c3d þ bc1c3ðbþ dÞðN   1Þ
;
xMM ¼
c3½bðc3   c2Þ þ ðc3   c1ÞdN þ ac2fc3½dðN   1Þ   N þ c2Ng
c3dðN   1Þ
ð22Þ
Since the fixed points and Eqs 18–20 are functions of several parameters, which makes the
analysis exceedingly complex, we investigate the dynamics and the stability in three more spe-
cific scenarios. In each scenario we investigate the effect of the multiplication factors and
group size on the dynamics. In what follows we show examples of the results for specific values
of the parameters. Increasing the value of a, b and d, or reducing the value of c1, c2, c3 changes
the trajectories and velocity of the dynamics but the direction and the position of the equilibria
remains unaltered.
Scenario 1
c2<c1<c3 (a common occurrence in multiple myeloma)
In multiple myeloma the contributions of the three types of cells (OC, OB, and MM) are
clearly different. As mentioned above, MM cells produce growth factors and cytokines at
higher levels than OB and OC cells. In the presence of MM cells, OC cells are also stimulated
to produce more growth factors. Hence, it seems reasonable to study a scenario in which
c2<c1<c3. Whenever the net benefit of diffusible factors that are secreted by MM cells is greater
than the benefit that OC cells can obtain through the diffusible factors produced by OB, there
exists a polymorphic stable point between MM and OC. Fig 2 shows an example of this sce-
nario. While OB and OC cells are in equilibrium in the absence of MM cells, the presence of
MM cells destabilizes that equilibrium and makes the population evolve to a stable mixed equi-
librium of MM and OC cells, regardless of the initial frequencies (Fig 3). As the population
approaches the stable point, OB cells disappear. In this process, the risk of bone fracture dra-
matically increases, a typical occurrence in multiple myeloma, which the model therefore
explains as a perturbation of the OB-OC equilibrium by MM cells. Even a tiny fraction of MM
cells in the population is able to change the dynamics and lead to an increased risk of bone
fracture. Increasing the contribution (that is, the amount of diffusible factors secreted) by OC
and MM cells increases their own fitness, while for OB increasing contributions decreases fit-
ness (Fig 4).
The size (N) of randomly composed group in our model is, essentially, the number of cells
in the diffusion range of the growth factors of the focal individual. Group size has an important
role in the evolutionary dynamic of the game. For example, if N = 2 (i.e. pairwise interaction)
the dynamics described above changes and the game has two stable points on the OB-OC and
OC-MM edges, and an interior saddle point (Fig 5). The presence of this interior saddle point
reveals already a fundamental difference between the pairwise model [13] and our model with
collective interactions (Fig 2): in our model a single MM cell is enough to lead the system from
the healthy OB-OC equilibrium to the OC-MM equilibrium, whereas in the pairwise model a
large number of MM cells are necessary. The effect of N on the position of the two fixed points
of our system is described in the Fig 6.
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Fig 2. Example of the dynamics for scenario 1. In the presence of a small number of MM cells, the stable point on the OB-OC border
becomes a saddle point and clonal selection leads to a stable coexistence of OC and MM cells. (N = 10, c3 = 1.4, c2 = 1.2, c1 = 1). The
arrows show the direction of the dynamics, and the colors show its speed (the euclidean distance between the frequencies at time t and t+1).
doi:10.1371/journal.pone.0168856.g002
Fig 3. Effect of initial frequencies on the dynamics for scenario 1. Different initial frequencies of OC, OB, and MM cells do not change the final
state of the population. Parameters as in Fig 2.
doi:10.1371/journal.pone.0168856.g003
Evolutionary Dynamics of Multiple Myeloma
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In the game defined in Fig 2, when the OC and MM phenotypes coexist, their frequencies
are constant with d (rOB,MM), and increase with b (where a has constant value 1). There may
exist 3 types of stable points based on the values of b and d, a stable point between OC and
MM, a stable point between OC and OB, and two stable points on the OC-MM and OC-OB
(Fig 7). Fig 8 shows the two last cases. Note that MM cells (Fig 8a) are unable to modify the sta-
ble equilibrium between OB and OC cells if b (the effect of MM and OC on each other) is low
(similar to the dynamics observed with pairwise interactions). If b is low enough, a further
effect is that the stable mixed equilibrium of MM and OC cells turns into a saddle point.
Fig 4. Fitness of the three cell types as a function of their contribution (cost) for scenario 1. As the value of cost increases the fitness of OC and
MM increases and the fitness of OB decreases. Same parameters as Fig 2.
doi:10.1371/journal.pone.0168856.g004
Fig 5. Dynamics with pairwise interactions in scenario 1. The dynamics described in Fig 2 changes when
N = 2, resulting in a new stable point between OC and OB, and a new polymorphic saddle point, in addition to
the stable point between OC and MM. The arrows show the direction of the dynamics, and the colors show its
speed (the euclidean distance between the frequencies at time t and t+1).
doi:10.1371/journal.pone.0168856.g005
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Scenario 2
c1 = c2 = c3 (which includes the model with pairwise interactions by Dingli et al. [13])
If the costs for OC, OB, and MM cells are equal (i.e., c1 = c2 = c3), then the following are
additional fixed points:
xOC ¼
1
2
; xOB ¼
1
2
; xMM ¼ 0
 
xOC ¼
1
2
; xOB ¼ 0; xMM ¼
1
2
 
xOC ¼
a2   ab
a2   2ab þ b2 þ ad þ bd
; xOB ¼
bðþd   aÞ
a2   2ab þ b2 þ ad þ bd
; xMM ¼
ad
a2   2ab þ b2 þ ad þ bd
 
ð23Þ
8
>
>
>
>
<
>
>
>
>
:
In this scenario we have three type of stable points: (i) a polymorphic stable point between
OC and OB, (ii) a polymorphic stable point between OC and MM and (iii) two stable points
on OC-OB and OC-MM edges of the simplex.
Fig 6. Effect of group size in scenario 1. The effect of group size N on the position of the fixed points on the OC-OB and OC-MM edges.
Same parameters as Fig 2.
doi:10.1371/journal.pone.0168856.g006
Fig 7. Effect of the parameters in scenario 1. The effect of a, b and d on the stable point in Fig 2. Changes in a and b, but not of d, change the stable
point.
doi:10.1371/journal.pone.0168856.g007
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Fig 8. Different types of dynamics for scenario 1. (A) The game has one polymorphic stable point between OB and OC. In this case,
clonal selection leads to the regular OC-OB balance and prevents invasion of MM cells. (B) The game has two polymorphic stable points. In
this case, the final state of the game depends on the initial frequencies. The arrows show the direction of the dynamics, and the colors show
its speed (the euclidean distance between the frequencies at time t and t+1).
doi:10.1371/journal.pone.0168856.g008
Fig 9. Examples of the dynamics for scenario 2. When c1 = c2 = c3 = 1, the game has (A) one stable point on the OC-OB edge if a<b and
a<2N/(N-1); (B) two stable points on the OC-OB and OC-MM edges if a<b and a<2N/(N-1), b+d>a and b<2N/(N-1); (C) one stable point on
the OC-MM edges if b+d>a and b<2N/(N-1). When the costs are not equal (bottom panels: c1 = 1, c2 = 1.2, c3 = 1.4) the dynamics and the
equilibria are different. N = 10. The arrows show the direction of the dynamics, and the colors show its speed (the euclidean distance
between the frequencies at time t and t+1).
doi:10.1371/journal.pone.0168856.g009
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If a = 1 and N = 2 the dynamics is equivalent to the one described by Dingli et al. [13]. N
however is important: while N has no effects on the position of the fixed points, it does affect
their stability (a result that is not captured by models with pairwise interactions, in which
N = 2): if a<b and a<2N/(N-1), all eigenvalues of the Jacobean matrix are negative at (xOC =
1/2, xOB = 1/2, xMM = 0), which is therefore a stable point of the system (and a healthy OC-OB
balance); if b+d>a and b<2N/(N-1), all eigenvalues of the Jacobean matrix are negative at
(xOC = 1/2, xOB = 0, xMM = 1/2), which is therefore a stable point of the system (and an
unhealthy one in which osteoblasts disappear).
Fig 9 shows three types of the dynamics for scenario 2. As the difference between b and d
increases the stable equilibrium moves from the healthy OB-OC polymorphism to the
MM-OC polymorphism typical of multiple myeloma, with a bistable system at intermediate
values of the difference. Note that the cost for OC, OB, and MM changes the evolutionary
dynamics at intermediate values of the b-(-d) distance (Fig 9).
Scenario 3
c3<c1<c2 (a case with a monomorphic stable point).
If c3<c1<c2, the population can have three types of stable points: a monomorphic equilib-
rium on the MM vertex, a polymorphic equilibrium on the OC-MM edge, and two polymor-
phic equilibria on the OC-MM and OC-OB edges. (The existence of the MM equilibrium can
be proved analytically: if b<[N(c1-c3)]/[c3(N-1)] and d>[N(c2-c3)]/[c3(N-1)], then the MM ver-
tex of the simplex is a stable point of the game because at (xOC = 0, xOB = 0, xMM = 1) all eigen-
values of the Jacobean matrix are negative.). Fig 10 shows an example of this scenario, in
which N affects the stable points.
Exploiting evolutionary dynamics in response to therapy
In the three scenarios we have analysed there are polymorphic equilibria either on the
OC-MM border or on the OC-OB border, or a monomorphic stable point on the MM vertex.
Fig 10. Examples of the dynamics for scenario 3. (A) For small group size (N = 10) the game has one stable point on the MM vertex. (B) If group
size increases (N = 50) the game has two stable points. (c1 = 1, c2 = 1.2, c3 = 0.8). The arrows show the direction of the dynamics, and the colors show
its speed (the euclidean distance between the frequencies at time t and t+1).
doi:10.1371/journal.pone.0168856.g010
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If the only stable point of the dynamics includes at least a fraction of MM cells, clearly killing
MM cells only slows down the dynamics, without leading to an effective, long-lasting treat-
ment. However, in scenarios that include the OC-OB equilibrium, changing the parameters of
the system or the fraction of cell types may affect the dynamics and change the equilibrium of
the system.
For example, consider the case in which there are two stable points, on the OC-OB and
OC-MM borders (Fig 8b). It may be possible, by removing some of the MM cells, or by adding
OB cells, to make the population evolve to the OC-OB mixed equilibrium, rather than to the
MM-OC equilibrium (Fig 11). The same result can be achieved by changing the parameters of
the game. Understanding that tumor-stroma interactions are a system with multiple equilibria,
therefore, could help devise strategies to change the dynamics and make the tumor evolve to
the healthy OC-OB equilibrium.
Differences with the model of pairwise interactions
Given the linear nature of the payoffs, it is possible, in principle, to construct a game with pair-
wise interactions that is equivalent to our multi-player collective-interaction game, similar to
what can be done for linear public goods games [18]. The payoff of the transformed pairwise
game equivalent to ours is given by
N   1
N
c1r1;1 c2r1;2 c3r1;3
c1r2;1 c2r2;2 c3r2;3
c1r3;1 c2r3;2 c3r3;3
0
B
@
1
C
Aþ
1
N
c1ðr1;1   NÞ
c2ðr2;2   NÞ
c3ðr3;3   NÞ
0
B
@
1
C
A:~1
T ð24Þ
Note that this is different from the pairwise game analyzed by Dingli et al. [13]; the core dif-
ference between their model and ours is that in our model interactions are collective (with
N>2) rather than pairwise (N = 2).
Fig 11. Effect of reducing the fraction of MM cells. (A) If a population is modified by reducing the fraction of MM cells (1, dotted arrow), it can be
moved into the basin of attraction of the stable point on the OC-OB edge, and it will then evolve (2, continuous arrow) to the healthy OC-OB equilibrium.
(B) Changes in frequencies over time corresponding to panel A, without therapy (dotted lines) or with therapy (continuous line) introduced at
generation 300. (c1 = 1.2, c2 = 1, c3 = 1.4).
doi:10.1371/journal.pone.0168856.g011
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Dingli et al. [13], however, use the same assumptions we use about the effect of the growth
factors produced by each type on each other cell type. That is, their model is equivalent to ours
if we set N = 2, a = 1 and c1 = c2 = c3. These assumptions, however, seem unrealistic. In reality,
not only are the costs different, but most importantly, clearly N>2 (that is, growth factors have
a collective effect on a large number of cells, not just one cell engaged in a pairwise interac-
tion). As we have seen, N has a strong effect on the stability of the fixed points. It is not surpris-
ing then, that our results (the number and nature of the equilibria) are not equivalent to the
model with pairwise interactions [13] if N>2. Fig 12 shows some of these differences, and we
discuss different cases here.
b>1: In this case the net benefit that OC cells obtain from MM cells is greater than what
they get from OB cells. In the pairwise model of Dingli et al. [13] the system has only one stable
point on the OC-MM edge and in this situation multiple myeloma eventually leads to bone
fracture, due to the lack of OB cells (left panel of Fig 12a). According to our model, instead, the
system can have different dynamics and stable points depending on the costs and the size of
the group (that is, the diffusion range of the growth factors) (middle and right panels of
Fig 12. Comparison with models with pairwise interactions. A comparison of our model and the pairwise game of Dingli et al. [13] with
b>1 (row A), b<1, b+d<1 (row B) or b<1, b+d>1 (row C). The arrows show the direction of the dynamics, and the colors show its speed (the
euclidean distance between the frequencies at time t and t+1).
doi:10.1371/journal.pone.0168856.g012
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Fig 12a). The differences have implications for therapy: reducing the number of MM cells in
our model may help to restore a healthy OB-OC balance (see middle panel of Fig 12a), an effect
that is not captured by the pairwise model of Dingli et al. [13]). In our model reducing the
number of MM cells results in a recovery of the normal balance OC-OB if for any p1 and p2
(where p1+p2 = 1, p1,p22[0,1]):
4ðp1 þ p2   1Þfbðc1 þ c3ÞðN   1Þp1 þ ½2c2 N   c3dðN   1Þp2g   aðc1 þ c2ÞðN   1Þð4p1p2   1Þ > 0 ð25Þ
b<1, b+d<1: Dingli et al. [13] showed that in this case, in a pairwise model, the normal bal-
ance OC-OB is the only stable equilibrium point of the system (left panel of Fig 12b). This is
the case in our model as well (middle panel of Fig 12b) if c2<c1<c3, but not if we change the
values of the costs and N (right panel of Fig 12b). In our model, instead, an additional
MM-OC stable equilibrium is possible.
b<1, b+d>1: In this case the pairwise model [13] has two stable points on the OC-OB and
OC-MM edges (left panel of Fig 12c), while our model has different dynamics and equilibria
(middle and right panels of Fig 12c). In particular, in our model the OC-MM stable equilib-
rium can be absent, which suggests that reducing b, for instance by inhibiting MIP-1α or IL-1β
[19, 20] may be beneficial. This was already observed by Dingli et al. [13], and is in agreement
with clinical observations [21, 22]. In our model this result is more realistic under certain
parameters (middle panel of Fig 12c), as the coexistence of OB and OC can be the only stable
equilibrium (whereas in the pairwise model of Dingli et al. [13], there is an additional OC-MM
equilibrium, and hence the population must be pushed outside its basin of attraction); on the
other hand, for different parameters (right panel of Fig 12c), a pure MM population is the only
stable outcome of the dynamics.
Discussion
As the interactions between cancer cells and stromal cells depend on the effect of diffusible fac-
tors with autocrine and paracrine effects, tumor-stroma interactions are frequency-dependent
processes that can be analyzed in the framework of evolutionary game theory. Our analysis of
tumor-stroma interactions in multiple myeloma departs from previous work [13] because of
our assumption that cells are engaged in collective interactions rather than pairwise interac-
tions [13]. Assuming collective interactions is more realistic, as growth factors produced by
both cancer and stromal cells have autocrine and paracrine effects that are clearly not limited
to just one other interacting cells; growth factors have collective effects on multiple cells, and
each cell’s fitness is influenced by the production of growth factors by all the cells within the
diffusion range of the factors.
As we have seen, the dynamics of tumor-stroma cooperation revealed by our model with
collective interactions is more complex that observed in a model with pairwise interactions
[13], and it leads to fundamental differences in the results. Like in the pairwise model analyzed
by Dingli et al. [13] we observe the co-existence of two strategies when one of the three types is
introduced, even at low frequency, in the population. In the presence of MM cells, the nature
of the OB-OC equilibrium can change from a stable coexistence (a healthy balance of OB and
OC cells) to a saddle point leading to an OC-MM equilibrium, which explains in part the path-
ological condition of bones observed with multiple myeloma, as the lack of OB cells, increases
the risk of bone fracture [23, 24] a result also observed in the pairwise model [13].
Our results, however, show a fundamental difference. Dingli et al. [13] observe that when
the net benefit that OC cells obtain from MM cells is greater than what they get from OB cells
(b>1), which, as they point out, is generally the case [16, 25], the only stable equilibrium is the
co-existence of MM and OC cells. Only if b<1 OB and OC cells can re-establish a stable
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healthy equilibrium, free from MM cells. In the pairwise model [13], in short, under realistic
parameters (b>1) a pathological condition is inevitable when even a single MM cell is intro-
duced in the population. In our model, instead, even with b>1 a reduction in the amount of
MM cells can induce a change leading to a balance of OC and OB and the extinction of the
MM cells (Fig 11). Additionally, the same result can be achieved, in principle, by increasing
the fraction of osteoblasts.
Our model suggests, therefore, that therapies that aim at reducing the number of MM cells
(for instance, protease inhibitors like Bortezomib [26–28], which is currently used in the U.S.
for treating multiple myeloma) could be effective against multiple myeloma, a result that is not
captured by a pairwise model [13]. In addition, it shows that extinction of malignant plasma
cells could be achieved by increasing the number of osteoblasts, a cell therapy approach that
might be feasible [29]. Finally, as we have seen, our model reveals that in other scenarios the
dynamics of multiple myeloma can be more complex, with additional equilibria in which MM
cells persist, or the collapse of MM cells and the return to a healthy balance between OB and
OC cells.
Tumor-stroma interactions are, like other frequency-dependent selection processes, not
intuitive, and game theory models can help understand the logic of their dynamics and, as a
consequence, the feasibility of possible therapies. Our result that the malignant plasma cells
may go extinct if they fall below a critical threshold required to model multiple myeloma using
a model of collective interactions, which is more realistic than the assumption of pairwise
interactions used previously.
Clearly one could add further realism to the model. In particular, we have assumed that the
effect of the growth factors secreted by the cells is a linear function of their concentration,
while the effect of growth factor is usually a nonlinear function [4, 29, 30], and it is known that
non-linear benefits can lead to different dynamics. We have also assumed that cells interact at
random in a well-mixed population, as if multiple myeloma was a purely liquid tumor; in real-
ity, however, multiple myeloma could be considered in part a spatially structured population,
and it is known that spatial structure can also affect the dynamics of public goods, especially
with linear benefits [31]. It would be interesting to understand how nonlinearities and spatial
structure in a collective action model affect the dynamics of tumor-stroma interactions.
The analysis of multiple myeloma made by Dingli et al. [13] has been pivotal in introducing
game theory in the study of cooperation between tumor and the microenvironment. By
extending their model to a model with collective interactions, we showed some fundamental
results that a simple model with pairwise interactions could not reveal. We hope this will stim-
ulate further analysis and further use of evolutionary game theory in the study of cancer
dynamics.
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